Richard Anderson
Stock Analyst at Wedbush
(3.69)
# 576
Out of 4,805 analysts
137
Total ratings
56.34%
Success rate
2.5%
Average return
Main Sectors:
Stocks Rated by Richard Anderson
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
SAFE Safehold | Reiterates: Neutral | $20 | $15.92 | +25.63% | 5 | Apr 1, 2025 | |
NHI National Health Investors | Reiterates: Outperform | $88 | $71.46 | +23.15% | 4 | Mar 17, 2025 | |
CTRE CareTrust REIT | Reiterates: Underperform | $26 | $27.41 | -5.14% | 3 | Mar 14, 2025 | |
STRW Strawberry Fields REIT | Maintains: Outperform | $12 → $14 | $10.90 | +28.44% | 2 | Mar 5, 2025 | |
VTR Ventas | Maintains: Outperform | $69 → $78 | $65.59 | +18.92% | 7 | Feb 14, 2025 | |
DOC Healthpeak Properties | Maintains: Outperform | $24 → $27 | $18.64 | +44.85% | 3 | Feb 14, 2025 | |
WELL Welltower | Upgrades: Outperform | $145 → $167 | $141.49 | +18.03% | 5 | Feb 14, 2025 | |
UMH UMH Properties | Reiterates: Neutral | $20 | $17.13 | +16.75% | 4 | Jan 13, 2025 | |
DEI Douglas Emmett | Upgrades: Outperform | $19 → $21 | $14.18 | +48.10% | 2 | Jan 2, 2025 | |
HR Healthcare Realty Trust | Downgrades: Underperform | $18 → $16 | $15.55 | +2.89% | 8 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $81 → $70 | $61.59 | +13.65% | 5 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $34 → $33 | $30.79 | +7.18% | 3 | Jan 2, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $72 | $58.44 | +23.20% | 1 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $110 | $80.82 | +36.10% | 7 | Dec 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $209 | $156.30 | +33.72% | 5 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $40 | $33.86 | +18.13% | 3 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $118 → $131 | $111.71 | +17.27% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $68 → $75 | $66.86 | +12.17% | 5 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $264 → $301 | $271.95 | +10.68% | 8 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $49 | $41.07 | +19.31% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $45 | $32.15 | +39.97% | 3 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $28 → $33 | $25.69 | +28.45% | 3 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $154 → $184 | $157.85 | +16.57% | 4 | Aug 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $22 | $14.22 | +54.71% | 2 | May 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $17 | $10.07 | +68.82% | 3 | May 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $51 | $47.81 | +6.67% | 2 | May 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $59 → $49 | $46.33 | +5.76% | 5 | Apr 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $45 | $33.96 | +32.51% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $67 | $55.83 | +20.01% | 2 | Mar 28, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $11 → $7.5 | $2.37 | +216.46% | 5 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $94 | $87.25 | +7.74% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $14 | $9.38 | +49.25% | 2 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $16.93 | -5.49% | 5 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $34 | $37.56 | -9.48% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $179 | $200.39 | -10.67% | 1 | Oct 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $4.07 | - | 2 | May 7, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $7.61 | - | 5 | Nov 6, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $3.78 | - | 2 | Jul 10, 2017 |
Safehold
Apr 1, 2025
Reiterates: Neutral
Price Target: $20
Current: $15.92
Upside: +25.63%
National Health Investors
Mar 17, 2025
Reiterates: Outperform
Price Target: $88
Current: $71.46
Upside: +23.15%
CareTrust REIT
Mar 14, 2025
Reiterates: Underperform
Price Target: $26
Current: $27.41
Upside: -5.14%
Strawberry Fields REIT
Mar 5, 2025
Maintains: Outperform
Price Target: $12 → $14
Current: $10.90
Upside: +28.44%
Ventas
Feb 14, 2025
Maintains: Outperform
Price Target: $69 → $78
Current: $65.59
Upside: +18.92%
Healthpeak Properties
Feb 14, 2025
Maintains: Outperform
Price Target: $24 → $27
Current: $18.64
Upside: +44.85%
Welltower
Feb 14, 2025
Upgrades: Outperform
Price Target: $145 → $167
Current: $141.49
Upside: +18.03%
UMH Properties
Jan 13, 2025
Reiterates: Neutral
Price Target: $20
Current: $17.13
Upside: +16.75%
Douglas Emmett
Jan 2, 2025
Upgrades: Outperform
Price Target: $19 → $21
Current: $14.18
Upside: +48.10%
Healthcare Realty Trust
Jan 2, 2025
Downgrades: Underperform
Price Target: $18 → $16
Current: $15.55
Upside: +2.89%
Jan 2, 2025
Downgrades: Underperform
Price Target: $81 → $70
Current: $61.59
Upside: +13.65%
Jan 2, 2025
Upgrades: Outperform
Price Target: $34 → $33
Current: $30.79
Upside: +7.18%
Dec 17, 2024
Initiates: Neutral
Price Target: $72
Current: $58.44
Upside: +23.20%
Dec 6, 2024
Maintains: Neutral
Price Target: $120 → $110
Current: $80.82
Upside: +36.10%
Oct 25, 2024
Reiterates: Outperform
Price Target: $209
Current: $156.30
Upside: +33.72%
Sep 20, 2024
Reiterates: Outperform
Price Target: $40
Current: $33.86
Upside: +18.13%
Aug 5, 2024
Maintains: Outperform
Price Target: $118 → $131
Current: $111.71
Upside: +17.27%
Aug 5, 2024
Maintains: Neutral
Price Target: $68 → $75
Current: $66.86
Upside: +12.17%
Aug 5, 2024
Maintains: Neutral
Price Target: $264 → $301
Current: $271.95
Upside: +10.68%
Aug 5, 2024
Maintains: Outperform
Price Target: $45 → $49
Current: $41.07
Upside: +19.31%
Aug 5, 2024
Maintains: Outperform
Price Target: $44 → $45
Current: $32.15
Upside: +39.97%
Aug 5, 2024
Maintains: Outperform
Price Target: $28 → $33
Current: $25.69
Upside: +28.45%
Aug 5, 2024
Maintains: Outperform
Price Target: $154 → $184
Current: $157.85
Upside: +16.57%
May 30, 2024
Reiterates: Outperform
Price Target: $22
Current: $14.22
Upside: +54.71%
May 28, 2024
Reiterates: Neutral
Price Target: $17
Current: $10.07
Upside: +68.82%
May 17, 2024
Reiterates: Outperform
Price Target: $51
Current: $47.81
Upside: +6.67%
Apr 25, 2024
Downgrades: Neutral
Price Target: $59 → $49
Current: $46.33
Upside: +5.76%
Apr 22, 2024
Initiates: Neutral
Price Target: $45
Current: $33.96
Upside: +32.51%
Mar 28, 2024
Reiterates: Neutral
Price Target: $67
Current: $55.83
Upside: +20.01%
Feb 20, 2024
Downgrades: Neutral
Price Target: $11 → $7.5
Current: $2.37
Upside: +216.46%
Oct 3, 2023
Initiates: Outperform
Price Target: $94
Current: $87.25
Upside: +7.74%
Oct 3, 2023
Initiates: Neutral
Price Target: $14
Current: $9.38
Upside: +49.25%
Oct 3, 2023
Initiates: Outperform
Price Target: $16
Current: $16.93
Upside: -5.49%
Oct 3, 2023
Initiates: Neutral
Price Target: $34
Current: $37.56
Upside: -9.48%
Oct 3, 2023
Initiates: Neutral
Price Target: $179
Current: $200.39
Upside: -10.67%
May 7, 2018
Upgrades: Neutral
Price Target: n/a
Current: $4.07
Upside: -
Nov 6, 2017
Upgrades: Neutral
Price Target: n/a
Current: $7.61
Upside: -
Jul 10, 2017
Upgrades: Buy
Price Target: n/a
Current: $3.78
Upside: -